Everidis introduces probiotic drops for kids

ST. LOUIS Everidis Health Sciences announced last week that it would begin distribution of BioGaia Probiotic Drops, a probiotic formulated for children. According to the company, the drop-form delivery system is the first in probiotics.

BioGala Drops contains L. reuteri—a double-blind, placebo-controlled study published online in the January edition of the Journal of Pediatrics found that L. reuteri improved gut function and feeding tolerance in formula-fed pre-term newborns.

Review board rules against Osteo-Bi Flex ad claims

NEW YORK NBTY lost its appeal to The National Advertising Review Board, the board announced Monday, which recommended that the company discontinue use of “Double Strength” and “Triple Strength” descriptors on Osteo-Bi Flex product packaging and in other advertising unless those terms are qualified to indicate that they refer to the level of key ingredients in each individual caplet and does not imply greater product performance or efficacy.

The appeal originated from a monitoring case opened by the National Advertising Division of the Council of Better Business Bureaus. As part of NAD’s routine monitoring program, NAD requested substantiation for certain claims made by Rexall Sundown (owned by NBTY) for its Osteo Bi-Flex dietary supplement.

The panel also recommends that Rexall remove its claims that the Boswellia serrata extract in 5-LOXIN is 10 times more concentrated than typical Boswellia serrata extracts unless those claims are presented in a context that does not imply that the increased concentration results in increased product performance or efficacy.

“Gary’s extensive experience in building world-class consumer brands aligns perfectly with our growth objectives,” stated Connie Barry, Pharmavite president and chief executive officer. “His demonstrated thought-leadership, combined with his dedication and commitment to the continued growth and vitality of Pharmavite, will serve to solidify Pharmavite as an industry leader committed to offering high-quality, science-based products.”

In this new position, Kuchta will lead the company’s strategic marketing initiatives and will report to Barry.

He previously served as Pharmavite’s vice president of marketing—new products/innovation.

Prior to joining Pharmavite in 2006, Kuchta served as marketing director at Unilever, where he was responsible for the Dove, Suave, Sunsilk, Thermasilk and Finesse businesses in the U.S.

Kuchta holds a Masters of Business Administration from the University of Chicago and an undergraduate degree in Economics from the University of Notre Dame. He will continue to be based at Pharmavite’s headquarters in Northridge, California.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry